91 related articles for article (PubMed ID: 24850606)
1. [Optimization of long-term hypolipidemia treatment of patients with myocardial infarction in combination with non-alcoholic steatohepatitis].
Georgian Med News; 2014 Apr; (229):53-8. PubMed ID: 24850606
[TBL] [Abstract][Full Text] [Related]
2. [Optimization of long-term treatment with rosuvastatin of patients with myocardial infarction in combination with non-alcoholic steatohepatitis].
Skrypnyk IM; Dubrovins'ka TV
Lik Sprava; 2014; (5-6):113-21. PubMed ID: 25906659
[TBL] [Abstract][Full Text] [Related]
3. [Negative effects of termination statinotherapy in patients after acute coronary event with concominent non-alcoholic steatohepatitis].
Skrypnyk IM; Dubrovins'ka TV
Lik Sprava; 2014 Nov; (11):106-11. PubMed ID: 25528845
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M
Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
[TBL] [Abstract][Full Text] [Related]
5. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
Chitose T; Sugiyama S; Sakamoto K; Shimomura H; Yamashita T; Hokamaki J; Tsunoda R; Shiraishi S; Yamashita Y; Ogawa H
Atherosclerosis; 2014 Nov; 237(1):251-8. PubMed ID: 25262434
[TBL] [Abstract][Full Text] [Related]
6. Effect of two intensive statin regimens on progression of coronary disease.
Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
[TBL] [Abstract][Full Text] [Related]
7. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety comparison of different statins in elderly patients].
Chen Y; Jiang C; Liu M; Liu F; Fan Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Nov; 42(11):910-5. PubMed ID: 25620252
[TBL] [Abstract][Full Text] [Related]
10. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.
Ballantyne CM; Bertolami M; Hernandez Garcia HR; Nul D; Stein EA; Theroux P; Weiss R; Cain VA; Raichlen JS
Am Heart J; 2006 May; 151(5):975.e1-9. PubMed ID: 16644314
[TBL] [Abstract][Full Text] [Related]
11. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
[TBL] [Abstract][Full Text] [Related]
12. [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].
Kuznetsova MA; Vaulin NA; Masenko VP; Gratsianskiĭ NA
Kardiologiia; 2010; 50(2):21-5. PubMed ID: 20146674
[TBL] [Abstract][Full Text] [Related]
13. Reversible dysphasia and statins.
Davies GR
J Korean Med Sci; 2012 Apr; 27(4):458-9. PubMed ID: 22468114
[TBL] [Abstract][Full Text] [Related]
14. Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia.
Mazza F; Stefanutti C; Di Giacomo S; Vivenzio A; Fraone N; Mazzarella B; Bucci A
Am J Cardiovasc Drugs; 2008; 8(4):265-70. PubMed ID: 18690760
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.
Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
Atheroscler Suppl; 2004 Oct; 5(3):115-23. PubMed ID: 15531284
[No Abstract] [Full Text] [Related]
16. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
[TBL] [Abstract][Full Text] [Related]
17. [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].
Namal E; Sener N; Ulaş T; Akçalı Z; Oztekin E; Borlu F
Anadolu Kardiyol Derg; 2011 Dec; 11(8):703-10. PubMed ID: 22088858
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
[TBL] [Abstract][Full Text] [Related]
19. Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
Kurtoglu E; Balta S; Sincer I; Altas Y; Atas H; Yilmaz M; Korkmaz H; Erdem K; Akturk E; Demirkol S; Can C
Angiology; 2014 Oct; 65(9):788-93. PubMed ID: 24163120
[TBL] [Abstract][Full Text] [Related]
20. [Comment from the cardiologic viewpoint].
Lüscher TF
Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
